RedHill Biopharma (RDHL) Times Interest Earned: 2012-2023
Historic Times Interest Earned for RedHill Biopharma (RDHL) over the last 11 years, with Jun 2023 value amounting to $27.91.
- RedHill Biopharma's Times Interest Earned rose 377.26% to $27.91 in Q2 2023 from the same period last year, while for Jun 2023 it was -$1.20, marking a year-over-year increase of 87.34%. This contributed to the annual value of -$7.11 for FY2024, which is 640.43% down from last year.
- According to the latest figures from Q2 2023, RedHill Biopharma's Times Interest Earned is $27.91, which was up 140.40% from -$69.07 recorded in Q1 2023.
- In the past 5 years, RedHill Biopharma's Times Interest Earned ranged from a high of $167.30 in Q2 2019 and a low of -$69.07 during Q1 2023.
- For the 3-year period, RedHill Biopharma's Times Interest Earned averaged around -$10.17, with its median value being $2.02 (2022).
- In the last 5 years, RedHill Biopharma's Times Interest Earned spiked by 2,905.64% in 2019 and then slumped by 1,723.72% in 2023.
- RedHill Biopharma's Times Interest Earned (Quarterly) stood at $62.91 in 2019, then slumped by 84.65% to $9.66 in 2020, then plummeted by 497.74% to -$38.41 in 2021, then rose by 20.52% to -$30.53 in 2022, then skyrocketed by 377.26% to $27.91 in 2023.
- Its Times Interest Earned was $27.91 in Q2 2023, compared to -$69.07 in Q1 2023 and -$30.53 in Q4 2022.